| Primary |
| Epilepsy |
30.2% |
| Convulsion |
29.2% |
| Product Used For Unknown Indication |
22.9% |
| Partial Seizures |
3.8% |
| Drug Use For Unknown Indication |
3.2% |
| Grand Mal Convulsion |
2.2% |
| Complex Partial Seizures |
1.9% |
| Bipolar Disorder |
1.3% |
| Depression |
1.3% |
| Headache |
1.0% |
| Affective Disorder |
0.3% |
| Anxiety |
0.3% |
| Asthma |
0.3% |
| Back Pain |
0.3% |
| Conversion Disorder |
0.3% |
| Cortical Dysplasia |
0.3% |
| Diagnostic Procedure |
0.3% |
| Mood Swings |
0.3% |
| Neuropathy Peripheral |
0.3% |
| Vertigo |
0.3% |
|
| Convulsion |
21.3% |
| Rash |
10.6% |
| Drug Ineffective |
6.9% |
| Vomiting |
6.9% |
| Grand Mal Convulsion |
5.6% |
| Somnolence |
5.6% |
| Stevens-johnson Syndrome |
5.6% |
| Headache |
4.4% |
| Exposure During Pregnancy |
3.8% |
| Overdose |
3.8% |
| Product Quality Issue |
3.8% |
| Adverse Drug Reaction |
2.5% |
| Drug Level Decreased |
2.5% |
| Hallucination |
2.5% |
| Memory Impairment |
2.5% |
| Treatment Noncompliance |
2.5% |
| Tremor |
2.5% |
| Viral Infection |
2.5% |
| Vision Blurred |
2.5% |
| Insomnia |
1.9% |
|
| Secondary |
| Epilepsy |
30.3% |
| Convulsion |
21.1% |
| Product Used For Unknown Indication |
13.2% |
| Asthma |
7.9% |
| Bipolar Disorder |
5.3% |
| Depression |
3.9% |
| Anxiety |
2.6% |
| Bronchitis |
2.6% |
| Convulsion Prophylaxis |
2.6% |
| Hypothyroidism |
2.6% |
| Myoclonic Epilepsy |
2.6% |
| Simple Partial Seizures |
2.6% |
| Insomnia |
1.3% |
| Weight Decreased |
1.3% |
|
| Overdose |
10.3% |
| Stevens-johnson Syndrome |
10.3% |
| Stress |
10.3% |
| Drug Exposure During Pregnancy |
6.9% |
| Somnolence |
6.9% |
| Vomiting |
6.9% |
| Cardiac Disorder |
3.4% |
| Convulsion |
3.4% |
| Dizziness |
3.4% |
| Drug Dispensing Error |
3.4% |
| Ill-defined Disorder |
3.4% |
| Loss Of Consciousness |
3.4% |
| Malaise |
3.4% |
| Mental Impairment |
3.4% |
| Mydriasis |
3.4% |
| Nausea |
3.4% |
| Platelet Count Decreased |
3.4% |
| Rapid Eye Movements Sleep Abnormal |
3.4% |
| Road Traffic Accident |
3.4% |
| Sinusitis |
3.4% |
|
| Concomitant |
| Epilepsy |
29.9% |
| Product Used For Unknown Indication |
28.4% |
| Convulsion |
11.4% |
| Multiple Sclerosis |
5.0% |
| Vitamin Supplementation |
3.5% |
| Headache |
3.0% |
| Prophylaxis |
3.0% |
| Migraine |
2.0% |
| Peritoneal Dialysis |
2.0% |
| Complex Partial Seizures |
1.5% |
| Depression |
1.5% |
| Abdominal Discomfort |
1.0% |
| Anxiety Disorder |
1.0% |
| Arthralgia |
1.0% |
| Asthma |
1.0% |
| Constipation |
1.0% |
| Hypertension |
1.0% |
| Hypothyroidism |
1.0% |
| Muscle Spasticity |
1.0% |
| Pain |
1.0% |
|
| Status Epilepticus |
26.3% |
| Convulsion |
13.2% |
| Vomiting |
7.9% |
| Nasal Discomfort |
5.3% |
| Nausea |
5.3% |
| Psychotic Disorder |
5.3% |
| Adverse Drug Reaction |
2.6% |
| Aggression |
2.6% |
| Amnesia |
2.6% |
| Angina Pectoris |
2.6% |
| Atrioventricular Block |
2.6% |
| Crying |
2.6% |
| Drug Ineffective |
2.6% |
| Fall |
2.6% |
| Feeling Abnormal |
2.6% |
| Grand Mal Convulsion |
2.6% |
| Headache |
2.6% |
| Kidney Infection |
2.6% |
| Meningioma |
2.6% |
| Off Label Use |
2.6% |
|
